Submitted by Anonymous (not verified) on 8 January 2026 - 14:34
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 40, Status: Authorised